← Eichor
Condition: Severe Covid 19 Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Severe Covid 19 Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605The Role of Obesity in Severe COVID-19 Pathophysiology
NA · 1 location(s) · Franciscus Gasthuis · NCT06968442A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Ge
Phase N/A · 1 location(s) · Pfizer · NCT05890612Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Phase 2 · 1 location(s) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infe · NCT07197164Imaging Immune Activation in COVID-19
Phase 2 · 1 location(s) · CellSight Technologies, Inc. · NCT04815096KIDney Injury in Times of COVID-19 (KIDCOV)
Phase N/A · 3 location(s) · University of California, San Francisco · NCT04705766Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection
Phase N/A · 1 location(s) · Juan Kang · NCT05835102Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Ye
Phase 3 · 73 location(s) · Pfizer · NCT05261139Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and C
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04582903A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not H
Phase 3 · 248 location(s) · Pfizer · NCT06679140Sequelae of Sars-CoV-2 Infections
Phase N/A · 1 location(s) · University of Giessen · NCT04442789A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterin
Phase 1 · 1 location(s) · Ruijin Hospital · NCT06693362Presynaptic Imaging in Major Depressive Episodes After COVID-19
Phase N/A · 1 location(s) · Centre for Addiction and Mental Health · NCT06086366Defibrotide for the Treatment of Severe COVID-19
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT04652115Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06082518A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are Hi
Phase 3 · 224 location(s) · Merck Sharp & Dohme LLC · NCT06667700Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04579471Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19
NA · 1 location(s) · Hospices Civils de Lyon · NCT06703034Convalescent Plasma as a Possible Treatment for COVID-19
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT04442191Severe COVID-19 Infection in Children Presenting to EDs in Israel and England
NA · 6 location(s) · Hadassah Medical Organization · NCT06434701Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Phase N/A · 1 location(s) · Columbia University · NCT04448145Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
Phase 2 · 1 location(s) · University of Texas Southwestern Medical Center · NCT05886816Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Phase 3 · 464 location(s) · AstraZeneca · NCT05624450A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
Phase 1 · 2 location(s) · ModeX Therapeutics, An OPKO Health Company · NCT07445971Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06490744IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condi
NA · 1 location(s) · Max-Planck-Institute of Psychiatry · NCT07197138Impact of COVID-19 Vaccines on Cerebrovascular Health
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT04992195
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.